Jefferies analyst Thomas Wei noted encouraging physician feedback on Synta Pharma's (NASDAQ: SNTA) Ganetespib for lung cancer.

"We hosted ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE